Advances in the Treatment Options for dMMR/MSI-H Metastatic Colorectal Cancer with Immunotherapy

Target Audience

This activity is designed to meet the educational needs of medical oncologists, radiation oncologists, surgeons, gastroenterologists, physician assistants, nurse practitioners, nurses, and other healthcare professionals involved in the treatment of colorectal cancer patients.

Program Overview

This activity will cover topics on the diagnosis, treatment, and management of patients with colorectal cancer.

Learning Objectives

Upon completion of this activity, participants should be better able to:

Assess the results of dMMR/MSI-H testing to determine appropriate patient selection of colorectal cancer (CRC)
Formulate treatment plans for metastatic CRC using immune checkpoint inhibition, alone or in combination with other therapies
Apply evidence-based strategies to monitor, recognize and effectively manage potential adverse events associated with immune checkpoint inhibition